<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">135465</id>
  <title nil="true"/>
  <common-name>ASP-4058</common-name>
  <description>ASP-4058 is an organic compound with the formula C19H12F6N4O2 and an average molecular weight of 442.32 g/mol. ASP-4058 belongs to the oxadiazoles, a subclass of azoles within the organic compounds. In terms of biological activity, the compound has two recorded protein targets, acting as a modulator of Sphingosine 1-phosphate receptor 1 (S1PR1) and Sphingosine 1-phosphate receptor 5 (S1PR5).</description>
  <cas>952565-91-2</cas>
  <pubchem-id>16755143</pubchem-id>
  <chemical-formula>C19H12F6N4O2</chemical-formula>
  <weight>442.3</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-14T18:24:54Z</created-at>
  <updated-at type="dateTime">2026-08-20T01:47:25Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB11819</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C[C@H](OC1=CC=C(C=C1C(F)(F)F)C1=NC(=NO1)C1=CC=C2NC=NC2=C1)C(F)(F)F</moldb-smiles>
  <moldb-formula>C19H12F6N4O2</moldb-formula>
  <moldb-inchi>InChI=1S/C19H12F6N4O2/c1-9(18(20,21)22)30-15-5-3-11(6-12(15)19(23,24)25)17-28-16(29-31-17)10-2-4-13-14(7-10)27-8-26-13/h2-9H,1H3,(H,26,27)/t9-/m0/s1</moldb-inchi>
  <moldb-inchikey>NJNXCJPSMWKXHO-VIFPVBQESA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">442.321</moldb-average-mass>
  <moldb-mono-mass type="decimal">442.08644462</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.54</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM131358</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>5-{5-[3-(trifluoromethyl)-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl]-1,2,4-oxadiazol-3-yl}-1H-1,3-benzodiazole</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Oxadiazoles</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0090603</sync-id>
  <structure-inchikey>NJNXCJPSMWKXHO-VIFPVBQESA-N</structure-inchikey>
  <structure-fingerprint>400000000000000020000002000021000080000000000000000000000000008002000010000000000000000000000020000000001000000000000000000004000080000000000000000000000000100000008080000021000040000000000000000000000240000020000000001000008000000000000000000000000000000000000100400000000048002000000000008000000000000000000004000000000040000000000000000100010840000008000000000c0000020000000000000002000000000000000000000100000000000000000000000000000200000000000000000000100001000040000000020000809000000020000000000400000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAfAAAAIgAAAIABBgBgAAAAAQMGIDQAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:49:35Z</structure-indexed-at>
</compound>
